Results 11 to 20 of about 96,770 (285)

Incidence of adverse events with telmisartan compared with ACE inhibitors: evidence from a pooled analysis of clinical trials

Patient Preference and Adherence, 2011
Giuseppe Mancia1, Helmut Schumacher21Universita degli Studi Milano-Bicocca, Ospedale San Gerardo di Monza, Milan, Italy; 2Boehringer Ingelheim Pharma GmbH and Co KG, Ingelheim, GermanyAbstract: Telmisartan is indicated for the prevention of ...
Mancia G, Schumacher H
doaj   +2 more sources

EVIDENCE-BASED CHOICE OF ACE INHIBITORS

Российский кардиологический журнал, 2012
Angiotensin-converting enzyme (ACE) inhibitors are currently one of the most frequently used groups of cardiovascular medications. In addition to wellknown indications, such as arterial hypertension (AH), chronic heart failure (CHF), and Type 2 diabetes ...
G. E. Gendlin, O. A. Miller, A. V. Melekhov   +2 more
doaj   +1 more source

ACE inhibitors in patients with acute myocardial infarction

Кардиоваскулярная терапия и профилактика, 2005
The article is devoted to modern perspectives of ACE inhibitor therapy in patients with acute myocardial infarction (AMI). ACE inhibitor efficacy is analyzed, according to the results of large randomized studies.
S. N. Tereshchenko, N. A. Dzhaiani
doaj   +2 more sources

Conformational changes of blood ACE in chronic uremia. [PDF]

PLoS ONE, 2012
BACKGROUND: The pattern of binding of monoclonal antibodies (mAbs) to 16 epitopes on human angiotensin I-converting enzyme (ACE) comprise a conformational ACE fingerprint and is a sensitive marker of subtle protein conformational changes.
Maxim N Petrov, Valery Y Shilo, Alexandr V Tarasov, David E Schwartz, Joe G N Garcia, Olga A Kost, Sergei M Danilov   +6 more
doaj   +1 more source

ACE Inhibitors

Nursing Standard, 1994
Sandy Gupta, Adam de Belder
europepmc   +2 more sources

Effects of adding tripterygium glycosides to angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on albuminuria in patients with diabetic nephropathy

Chronic Diseases and Translational Medicine, 2020
Introduction: Tripterygium glycosides (TGs) have been widely used in China to treat diabetic nephropathy (DN); however, proof of their use is scarce. The present study aimed to evaluate the effectiveness and safety of adding TGs to angiotensin-converting
Jin-Ying Fang, Yue Yang, Zheng Zhang, Shi-Min Jiang, Tian-Yu Yu, Wen-Ge Li   +5 more
doaj   +1 more source

Association of Angiotensin‐Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With the Risk of Hospitalization and Death in Hypertensive Patients With COVID‐19

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Despite its clinical significance, the risk of severe infection requiring hospitalization among outpatients with severe acute respiratory syndrome coronavirus 2 infection who receive angiotensin‐converting enzyme (ACE) inhibitors and ...
Rohan Khera, Callahan Clark, Yuan Lu, Yinglong Guo, Sheng Ren, Brandon Truax, Erica S. Spatz, Karthik Murugiah, Zhenqiu Lin, Saad B. Omer, Deneen Vojta, Harlan M. Krumholz   +11 more
doaj   +1 more source

Angiotensin-converting enzyme (ACE) inhibitor prescription affects non-small-cell lung cancer (NSCLC) patients response to PD-1/PD-L1 immune checkpoint blockers

OncoImmunology, 2020
Angiotensin-converting enzyme (ACE) inhibitors are frequently used to treat hypertension and congestive heart failure. Preclinical data show that ACE plays a role on both innate and adaptive immune responses. Since interactions between ACE inhibitors and
Soleine Medjebar, Caroline Truntzer, Anaïs Perrichet, Emeric Limagne, Jean-David Fumet, Corentin Richard, Arielle Elkrief, Bertrand Routy, Cédric Rébé, François Ghiringhelli   +9 more
doaj   +1 more source

Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on the patients with sepsis [PDF]

The Korean Journal of Internal Medicine, 2021
Background/Aims Inhibitors of the renin-angiotensin system, angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs), reportedly have anti-inflammatory effects.
Hyun Woo Lee, Jae Kyung Suh, Eunjin Jang, Sang-Min Lee   +3 more
doaj   +1 more source

THE CAPABILITIES OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CLINICAL PRACTICE: FOCUS ON VASOPROTECTION

Рациональная фармакотерапия в кардиологии, 2015
Data of large-scale research that shows comprehensive abilities of an angiotensin converting enzyme (ACE) inhibitors in clinical practice were represented.
D. B. Nebieridze, A. S. Safaryan
doaj   +3 more sources